» Articles » PMID: 31051301

Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) As Predictor for Positive Computed Tomography of the Head in Trauma Subjects

Overview
Journal World Neurosurg
Publisher Elsevier
Date 2019 May 4
PMID 31051301
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Traumatic brain injuries (TBIs) are largely underdiagnosed and may have persistent refractory consequences. Current assessments for acute TBI are limited to physical examination and imaging. Biomarkers such as glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase L1 (UCH-L1), and S100 calcium-binding protein B (S100B) have shown predictive value as indicators of TBI and potential screening tools.

Methods: In total, 37 controls and 118 unique trauma subjects who received a clinically ordered head computed tomography (CT) in the emergency department of a level 1 trauma center were evaluated. Blood samples collected at 0-8 hours (initial) and 12-32 hours (delayed) postinjury were analyzed for GFAP, UCH-L1, and S100B concentrations. These were then compared in CT-negative and CT-positive subjects.

Results: Median GFAP, UCH-L1, and S100B concentrations were greater in CT-positive subjects at both timepoints compared with CT-negative subjects. In addition, median UCH-L1 and S100B concentrations were lower at the delayed timepoint, whereas median GFAP concentrations were increased. As predictors of a positive CT of the head, GFAP outperformed UCH-L1 and S100B at both timepoints (initial: 0.89 sensitivity, 0.62 specificity; delayed: 0.94 sensitivity, 0.67 specificity). GFAP alone also outperformed all possible combinations of biomarkers.

Conclusions: GFAP, UCH-L1, and S100B demonstrated utility for rapid prediction of a CT-positive TBI within 0-8 hours of injury. GFAP exhibited the greatest predictive power at 12-32 hours. Furthermore, these results suggest that GFAP alone has greater utility for predicting a positive CT of the head than UCH-L1, S100B, or any combination of the 3.

Citing Articles

Efficacy of biomarkers and imaging techniques for the diagnosis of traumatic brain injury: challenges and opportunities.

Duerksen J, Lopez R, Tappia P, Ramjiawan B, Mansouri B Mol Cell Biochem. 2024; .

PMID: 39656395 DOI: 10.1007/s11010-024-05176-w.


A Systematic Review of Traumatic Brain Injury in Modern Rodent Models: Current Status and Future Prospects.

Balakin E, Yurku K, Fomina T, Butkova T, Nakhod V, Izotov A Biology (Basel). 2024; 13(10).

PMID: 39452122 PMC: 11504108. DOI: 10.3390/biology13100813.


Plasma biomarkers in chronic single moderate-severe traumatic brain injury.

Spitz G, Hicks A, McDonald S, Dore V, Krishnadas N, OBrien T Brain. 2024; 147(11):3690-3701.

PMID: 39315931 PMC: 11531850. DOI: 10.1093/brain/awae255.


Development of a time-resolved immunochromatographic test strip for rapid and quantitative determination of GFAP in serum.

Wang Y, Yu Z, Ning Z, Li M, Li W, Zhong Y Mikrochim Acta. 2024; 191(6):325.

PMID: 38739279 DOI: 10.1007/s00604-024-06385-2.


Diagnostic and Prognostic Values of S100B versus Neuron Specific Enolase for Traumatic Brain Injury; a Systematic Review and Meta-analysis.

Zarei H, Dizaji S, Toloui A, Yousefifard M, Esmaeili A Arch Acad Emerg Med. 2024; 12(1):e29.

PMID: 38572218 PMC: 10988180. DOI: 10.22037/aaem.v12i1.2222.